Bringing patient centricity and scale to decentralized trials
December 14, 2021
Tuesday, December 14, 2021 at 1pm EST | 10am PST | 7pm CET | 6pm GMT
Decentralized clinical trials have forced the industry to rethink their approach to study startup and associated regulations. Forthcoming, ICH E6 (R3) provides stakeholders tools to move from the customary habits of fixed checklists to a fit-for-purpose approach, that can be implemented now allowing for proactive planning and ultimately great adoption of innovative trial designs.